Trials. 2022 Dec 5;23(1):981. doi: 10.1186/s13063-022-06930-5.
NO ABSTRACT
PMID:36471449 | DOI:10.1186/s13063-022-06930-5
Categories
A novel Bayesian adaptive design incorporating both primary and secondary endpoints for randomized IIB chemoprevention study of women at increased risk for breast cancer
